Literature DB >> 2173727

Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.

N Kato1, O Yokosuka, M Omata, K Hosoda, M Ohto.   

Abstract

Hepatitis C virus (HCV) RNA was detected in the sera of patients with non-A, non-B chronic liver disease by polymerase chain reaction (PCR). RNA was extracted from the serum, reverse transcribed to cDNA, and amplified by PCR. With this method, 30 patients with non-A, non-B chronic liver disease and 10 healthy subjects were tested. HCV RNA was detected in 13 of 16 (81%) anti-HCV-positive patients and also in 7 of 14 (50%) anti-HCV-negative patients, but in none of 10 anti-HCV-negative healthy subjects. Specificity of this method was confirmed by direct sequencing of amplified cDNA segment. The nucleotide sequences (37 nucleotides) obtained from 15 patients showed only 68-78% homology compared with the prototype HCV nucleotide sequence. In addition, of 15 nucleotide sequences, there were 12 different types. But the translated amino acid sequences (12 amino acids) showed 83-100% homology compared with the prototype HCV amino acid sequence. These data suggest the majority of anti-HCV-positive patients are carriers of HCV. But to detect all the viremic patients, the anti-HCV antibody testing may be insufficient. Direct detection of HCV RNA may be useful in the study of virus replication and its association with various liver diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173727      PMCID: PMC296931          DOI: 10.1172/JCI114903

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection.

Authors:  M Tagawa; M Omata; K Okuda
Journal:  Virology       Date:  1986-07-30       Impact factor: 3.616

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing.

Authors:  M Tada; M Omata; M Ohto
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

6.  Hepatitis B virus RNA transcripts and DNA in chronic liver disease.

Authors:  O Yokosuka; M Omata; F Imazeki; Y Ito; K Okuda
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

7.  Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum. Analysis of 1063 specimens.

Authors:  Y Matsuyama; M Omata; O Yokosuka; F Imazeki; Y Ito; K Okuda
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

10.  Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

Authors:  F Bonino; B Hoyer; J Nelson; R Engle; G Verme; J Gerin
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  23 in total

1.  High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group.

Authors:  Y Shiratori; R Nakata; N Shimizu; H Katada; S Hisamitsu; E Yasuda; M Matsumura; T Narita; K Kawada; M Omata
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

Authors:  T L Fong; M Shindo; S M Feinstone; J H Hoofnagle; A M Di Bisceglie
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 3.  Hepatitis C: diagnosis and treatment.

Authors:  I Scotiniotis; C A Brass; P F Malet
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

4.  Hepatitis C Virus Infection in Haemodialysis Patients: "Wolf in Sheep's Clothing".

Authors:  G S Chopra; R M Gupta; S R Gedela; P P Varma; R Rai; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-05-30

5.  Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Hirokazu Miyatake; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shin-Ichiro Nakamura; Hideki Ohnishi; Kenji Kuwaki; Junichi Toshimori; Hiroaki Hagihara; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  Dig Dis Sci       Date:  2011-10-12       Impact factor: 3.199

6.  Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage.

Authors:  Y Tanji; M Hijikata; Y Hirowatari; K Shimotohno
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 7.  Viral markers in the treatment of hepatitis B and C.

Authors:  H Schmilovitz-Weiss; M Levy; N Thompson; G Dusheiko
Journal:  Gut       Date:  1993       Impact factor: 23.059

8.  Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.

Authors:  S Takano; M Omata; M Ohto; Y Satomura
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

9.  Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma.

Authors:  M A Gerber; Y S Shieh; K S Shim; S N Thung; A J Demetris; M Schwartz; G Akyol; S Dash
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

10.  Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.

Authors:  Eiman Aleem; Ayman Elshayeb; Nihal Elhabachi; Amal Refaat Mansour; Ahmed Gowily; Asmaa Hela
Journal:  Oncol Lett       Date:  2011-12-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.